S
Sushil Kumar
Researcher at University of Pennsylvania
Publications - 9
Citations - 518
Sushil Kumar is an academic researcher from University of Pennsylvania. The author has contributed to research in topics: Metastasis & Stem cell. The author has an hindex of 6, co-authored 8 publications receiving 244 citations.
Papers
More filters
Journal ArticleDOI
Notch ligand Dll1 mediates cross-talk between mammary stem cells and the macrophageal niche
Rumela Chakrabarti,Rumela Chakrabarti,Toni Celià-Terrassa,Sushil Kumar,Xiang Hang,Yong Wei,Abrar Choudhury,Julie Hwang,Jia Peng,Briana G. Nixon,John J. Grady,Christina DeCoste,Jie Gao,Johan H. van Es,Ming O. Li,Iannis Aifantis,Hans Clevers,Yibin Kang,Yibin Kang +18 more
TL;DR: Dll1cKO mice have a reduced number of MaSCs at different stages of mammary gland development in virgin and pregnant animals, and it is demonstrated that Dll1+ Ma SCs can both basal and luminal cells generate the important cellular components of the Mammary gland stem cell niche through inter-turning.
Journal ArticleDOI
Combining PARP with ATR inhibition overcomes PARP inhibitor and platinum resistance in ovarian cancer models
Hyoung Kim,Haineng Xu,Erin George,Dorothy Hallberg,Sushil Kumar,Veena Jagannathan,Sergey Medvedev,Yasuto Kinose,Kyle Devins,Priyanka Verma,Kevin Ly,Yifan Wang,Roger A. Greenberg,Lauren E. Schwartz,Neil Johnson,Robert B. Scharpf,Gordon B. Mills,Rugang Zhang,Victor E. Velculescu,Eric J. Brown,Fiona Simpkins +20 more
TL;DR: The authors show that the combination of PARP and ATR inhibitors increases the therapeutic response in PAR Pi and platinum resistant ovarium cancer PDX models, indicating that PARPi-ATRi is a highly promising strategy for OVCAs that acquire resistance to PARPi and platinum.
Journal ArticleDOI
ΔNp63-driven recruitment of myeloid-derived suppressor cells promotes metastasis in triple-negative breast cancer
Sushil Kumar,David W. Wilkes,Nina Samuel,Mario Andres Blanco,Anupma Nayak,Kevin Alicea-Torres,Christian Gluck,Satrajit Sinha,Dmitry I. Gabrilovich,Rumela Chakrabarti +9 more
TL;DR: Findings identify a unique crosstalk between &Dgr;Np63+ TNBC cells and MDSCs that promotes tumor progression and metastasis, which could be exploited in future combined immunotherapy/chemotherapy strategies for TNBC patients.
Journal ArticleDOI
Estrogen-dependent DLL1-mediated Notch signaling promotes luminal breast cancer
Sushil Kumar,Ratnesh Kumar Srivastav,David W. Wilkes,Taylor Ross,Sabrina Kim,Jules Kowalski,Srinivas Chatla,Qing Zhang,Anupma Nayak,Manti Guha,Serge Y. Fuchs,Christoforos Thomas,Rumela Chakrabarti +12 more
TL;DR: The studies show that DLL1, a Notch signaling ligand, is significantly overexpressed in ERα+ luminal breast cancer, and find that estrogen signaling stabilizes D LL1 protein by preventing its proteasomal and lysososmal degradations.
Journal ArticleDOI
Loss of ELF5–FBXW7 stabilizes IFNGR1 to promote the growth and metastasis of triple-negative breast cancer through interferon-γ signalling
Snahlata Singh,Sushil Kumar,Ratnesh Kumar Srivastava,Ajeya Nandi,Gatha Thacker,Hemma Murali,Sabrina Kim,Mary Baldeon,John W. Tobias,Mario Andres Blanco,Rizwan Saffie,M. Raza Zaidi,Satrajit Sinha,Luca Busino,Serge Y. Fuchs,Rumela Chakrabarti +15 more
TL;DR: It is shown that ELF5 loss disrupts IFNGR1 ubiquitination by FBXW7, thus enhancing IFN-γ signalling, neutrophil accumulation and PD-L1 expression to promote breast cancer progression and metastasis.